- Home
- DAWN vs SCSC Comparison
DAWN vs SCSC Comparison
Compare DAWN & SCSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAWN
- SCSC
- Stock Information
- Founded
- DAWN 2018
- SCSC 1992
- Country
- DAWN United States
- SCSC United States
- Employees
- DAWN N/A
- SCSC N/A
- Industry
- DAWN Biotechnology: Pharmaceutical Preparations
- SCSC Retail: Computer Software & Peripheral Equipment
- Sector
- DAWN Health Care
- SCSC Technology
- Exchange
- DAWN Nasdaq
- SCSC Nasdaq
- Market Cap
- DAWN 1.3B
- SCSC 1.1B
- IPO Year
- DAWN 2021
- SCSC 1994
- Fundamental
- Price
- DAWN $12.15
- SCSC $40.99
- Analyst Decision
- DAWN Strong Buy
- SCSC Hold
- Analyst Count
- DAWN 7
- SCSC 1
- Target Price
- DAWN $36.33
- SCSC N/A
- AVG Volume (30 Days)
- DAWN 1.1M
- SCSC 198.7K
- Earning Date
- DAWN 02-24-2025
- SCSC 01-30-2025
- Dividend Yield
- DAWN N/A
- SCSC N/A
- EPS Growth
- DAWN N/A
- SCSC N/A
- EPS
- DAWN N/A
- SCSC 2.54
- Revenue
- DAWN $101,953,000.00
- SCSC $3,021,788,000.00
- Revenue This Year
- DAWN N/A
- SCSC $2.58
- Revenue Next Year
- DAWN $34.82
- SCSC $4.90
- P/E Ratio
- DAWN N/A
- SCSC $15.74
- Revenue Growth
- DAWN N/A
- SCSC N/A
- 52 Week Low
- DAWN $11.13
- SCSC $31.01
- 52 Week High
- DAWN $18.07
- SCSC $53.90
- Technical
- Relative Strength Index (RSI)
- DAWN 44.59
- SCSC 21.54
- Support Level
- DAWN $11.93
- SCSC $49.32
- Resistance Level
- DAWN $13.53
- SCSC $50.76
- Average True Range (ATR)
- DAWN 0.56
- SCSC 1.67
- MACD
- DAWN 0.03
- SCSC -1.02
- Stochastic Oscillator
- DAWN 35.21
- SCSC 2.37
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor.
About SCSC ScanSource Inc.
ScanSource Inc provides value-added services for technology manufacturers and sells to resellers in specialty technology markets. The firm's operations are organized in two segments: Specialty Technology Solutions and Modern Communications and Cloud. It generates maximum revenue from the Specialty Technology Solutions segment. The Specialty Technology Solutions segment includes the company's business in mobility and barcode, POS, payments, security and networking technologies. Geographically, it derives a majority of revenue from the United States.